Related Experiment Video
Updated: Jun 10, 2025

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.6K
Disease trajectories before dementia: evidence from a large-scale community-based prospective study
Jialin Li1,2, Ding Xia3, Mei Cui4
1State Key Laboratory of Genetic Engineering, Human Phenome Institute, Zhangjiang Fudan International Innovation Center, Fudan University, Shanghai, China.
The British Journal of Psychiatry : the Journal of Mental Science
|October 11, 2024
Summary
Circulatory, metabolic, and respiratory diseases precede dementia onset by 5-15 years. Midlife cardiometabolic dysfunction offers key targets for dementia prevention and screening.
Area of Science:
- Neuroscience
- Epidemiology
- Genetics
Background:
- Systemic diseases can influence dementia onset, but the precise timing of precursor diseases is unclear.
- Understanding disease trajectories preceding dementia is crucial for effective prevention strategies.
Purpose of the Study:
- To characterize the full spectrum of temporal disease trajectories before dementia.
- To identify precursor diseases for dementia risk management and primary prevention.
Main Methods:
- Utilized UK Biobank data from 434,266 dementia-free participants and 4,638 with dementia.
- Employed phenome-wide association analysis, paired directional test, and association quantification to construct disease trajectories.
- Stratified trajectories by dementia subtypes, gender, age, and Apolipoprotein E (ApoE) status.
Main Results:
- Identified three clusters of disease trajectories preceding all-cause dementia, initiated by circulatory, metabolic, and respiratory diseases 5-15 years prior.
- Specific trajectories identified, including chronic ischemic heart disease leading to cerebral infarction or chronic renal failure before vascular dementia.
- Lipid metabolism disorders were consistently present across trajectories, irrespective of dementia subtype, gender, age, or ApoE status.
Conclusions:
- Provides a comprehensive view of longitudinal disease trajectories preceding dementia.
- Highlights midlife cardiometabolic dysfunction as a potential target for dementia screening and prevention efforts.
Related Concept Videos
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
Longitudinal Research
11.9K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.9K
Alzheimer's Disease: Treatment
166
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
166
Longitudinal Studies
140
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
140
Atherosclerosis II: Clinical manifestations and prevention
2
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
2

